June 25, 2020 / 10:02 PM / 14 days ago

BRIEF-Interpace Biosciences Reports Qtrly Loss Per Share $2.32

June 25 (Reuters) - Interpace Biosciences Inc:

* INTERPACE BIOSCIENCES ANNOUNCES FIRST QUARTER 2020 FINANCIAL AND BUSINESS RESULTS

* Q1 REVENUE $9.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $8.9 MILLION

* QTRLY LOSS PER SHARE $2.32

* Q1 EARNINGS PER SHARE VIEW $-1.24 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below